🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being conducted to evaluate the safety of MK-0954A (L100/H12....
Status
Completed
Location
Multiple Locations
Start Date
2011-03-29
Trial ID
NCT01307033
Treatments Being Tested
The purpose of this study is to evaluate the non-inferiority clinical effic...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02483936
Study purpose: African Americans with hypertension and markers of metabolic...
Status
Withdrawn
Location
University of Michigan Health System
Start Date
2011-02
Trial ID
NCT01432106
Treatments Being Tested
To evaluate the blood pressure efficacy between losartan and valsartan at e...
Status
Completed
Location
Multiple Locations
Start Date
2007-05-01
Trial ID
NCT00546754
Treatments Being Tested
This is a 16-week study to evaluate high systolic and diastolic blood press...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00289887
Treatments Being Tested
This study will be performed only at the Jewish General Hospital. It will i...
Status
Withdrawn
Location
Cardiovascular Prevention Centre, Jewish General Hospital
Start Date
2012-01
Trial ID
NCT01480791
Treatments Being Tested
This study will evaluate the safety and efficacy of a new combination of 3 ...
Status
Completed
Location
Hospital de Urgência e Emergência de Rio Branco
Start Date
2023-08-22
Trial ID
NCT05920005
A study to evaluate the effects of combination losartan versus combination ...
Status
Completed
Location
Multiple Locations
Start Date
2003-02-01
Trial ID
NCT00140959
The goal of this clinical trial is to determine whether a renin-guided anti...
Status
Not Yet Recruiting
Location
The Ottawa Hospital
Start Date
2026-09-01
Trial ID
NCT07687160
This study is being done to evaluate the efficacy, safety, and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT01302691